Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term 'Immune system via paracrine factors and cell-contact molecules' describes a complex physiological mechanism of immunomodulation rather than a single molecular target. This process is most notably associated with Mesenchymal Stem Cells (MSCs), which regulate the activity of T cells, B cells, and natural killer cells through two distinct but complementary pathways (Gao et al., 2016, 'Mesenchymal stem cells: a new strategy for immunosuppression'). The paracrine component involves the secretion of soluble factors such as Interleukin-10 (IL-10), Transforming Growth Factor-beta (TGF-β), and Indoleamine 2,3-dioxygenase (IDO), which create a suppressive chemical environment (Kyurkchiev et al., 2014, 'Secretion of immunomodulatory factors by mesenchymal stem cells'). Simultaneously, cell-contact molecules like PD-L1 and Fas ligand (FasL) interact directly with receptors on immune cells to trigger inhibitory signaling or apoptosis (Wang et al., 2014, 'Mesenchymal stem cells: immunomodulatory mechanisms and clinical applications'). While these pathways are critical for treating conditions like Graft-versus-Host Disease (GvHD) and autoimmune disorders, the entry is considered 'incorrect' as a target because it encompasses an entire system of diverse proteins and interactions rather than a specific, druggable molecule.
Modulation of the immune microenvironment through the simultaneous secretion of soluble anti-inflammatory mediators (paracrine) and direct physical interaction between cell-surface ligands and immune cell receptors (juxtacrine).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune system via paracrine factors and cell-contact molecules.